Virtual Medicinal Product (VMP) - Dolutegravir 50mg / Abacavir 600mg / Lamivudine 300mg tablets

Navigation

Name Details

Name Start Date End Date
Name Current Name Dolutegravir 50mg / Abacavir 600mg / Lamivudine 300mg tablets Start Date 02-04-2025 End Date
Previous Name Previous Name Generic Triumeq 50mg/600mg/300mg tablets Start Date 22-09-2014 End Date 01-04-2025
Abbreviated Name Abbreviated Name Dolutegravir 50mg / Abacavir 600mg / Lamivudine 300mg tab Start Date 02-04-2025

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
tablet
Unit Dose UOM
tablet

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Oral
Form
Oral tablet
Ontology Form/Route
tablet.oral
Name Basis
Other

Codes

ATC Code
J05AR13
BNF Start Date End Date
Current BNF 05030100 Start Date 04-04-2022 End Date
Previous BNF 05030100 Start Date 03-03-2015 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
27623511000001104 22-09-2014

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Abacavir sulfate Based on Base Substance Abacavir 600 mg
Dolutegravir sodium Based on Base Substance Dolutegravir 50 mg
Lamivudine Based on Ingredient Substance 300 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
30 tablet